The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Abstract
Activated mononuclear cells appear to be important effector cells in autoimmune beta cell destruction leading to insulin-dependent (type 1) diabetes mellitus. Conditioned medium from activated mononuclear cells (from human blood) is cytotoxic to isolated rat and human islets of Langerhans. This cytotoxic activity was eliminated from crude cytokine preparations by adsorption with immobilized, purified antibody to interleukin-1 (IL-1). The islet-inhibitory activity and the IL-1 activity (determined by its comitogenic effect on thymocytes) were recovered by acid wash. Purified natural IL-1 and recombinant IL-1 derived from the predominant p I 7 form of human IL-1, consistently inhibited the insulin response. The p I 6 and p I 5 forms of natural IL-1 were ineffective. Natural and recombinant IL-1 exhibited similar dose responses in their islet-inhibitory effect and their thymocyte-stimulatory activity. Concentrations of IL-1 that inhibited islet activity were in the picomolar range. Hence, monocyte-derived p I 7 IL-1 may contribute to islet cell damage and therefore to the development of insulin-dependent diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Self-citationNucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationBottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., & Gamble, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130604 · Cited by 932
Determination of total serum insulin (IRI) in insulin-treated diabetic patients
Heding, L. G. (1972) · Diabetologia · doi:10.1007/bf01225569 · Cited by 705
Immune interferon: a pleiotropic lymphokine with multiple effects
Trinchieri, G., & Perussia, B. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90080-5 · Cited by 658
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., et al. (1984) · Nature · doi:10.1038/312721a0 · Cited by 640
New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat
Bonner-Weir, S., & Orci, L. (1982) · Diabetes · doi:10.2337/diab.31.10.883 · Cited by 499
The pancreatic islets in diabetes
Gepts, W., & Lecompte, P. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90417-4 · Cited by 349
Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans
Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A., Svenson, M., & Nielsen, J. H. (1986) · Diabetologia · doi:10.1007/bf02427283 · Cited by 324
Self-citationHuman leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Self-citationRosenwasser, L. J., & Dinarello, C. A. (1981) · Cellular Immunology · doi:10.1016/0008-8749(81)90034-4 · Cited by 219
Self-citationCytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans
Mandrup‐Poulsen, T., Bendtzen, K., Nielsen, J. H., Bendixen, G., & Nerup, J. (1985) · Allergy · doi:10.1111/j.1398-9995.1985.tb02681.x · Cited by 180
Self-citationMACROPHAGE-MEDIATED CYTOTOXICITY AGAINST CULTURED PANCREATIC ISLET CELLS
Schwizer, R. W., Leiter, E. H., & EVANS, R. (1984) · Transplantation · doi:10.1097/00007890-198406000-00002 · Cited by 63
Dinarello, C. A., Bernheim, H. A., Cannon, J. G., LoPreste, G., Warner, S. J. C., Webb, A. C., & Auron, P. E. (1985) · Lara D. Veeken · doi:10.1093/rheumatology/xxiv.suppl_1.59 · Cited by 50
Self-citationBiological Properties of Interleukins
Bendtzen, K. (1983) · Allergy · doi:10.1111/j.1398-9995.1983.tb01614.x · Cited by 43
Self-citationStudies on the active site of human leukocytic pyrogen
Dinarello, C. A., Bendtzen, K., & Wolff, S. M. (1982) · Inflammation · doi:10.1007/bf00910720 · Cited by 38
Self-citation
Cited by
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Self-citationSecretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationMetabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citation
Metadata
- Authors
- Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M.
- Venue
- Science
- Published
- 1986-06-20
- Volume
- 232
- Issue
- 4757
- Pages
- 1545-1547
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2058455617
- Cited by
- 529
- References
- 17
- FWCI
- 23.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.